Update from the 2009 ASCO Annual Meeting: The treatment of metastatic HER2-positive gastric cancer with chemotherapy and trastuzumab Journal Article

  


Author: Ilson, D. H.
Article Title: Update from the 2009 ASCO Annual Meeting: The treatment of metastatic HER2-positive gastric cancer with chemotherapy and trastuzumab
Abstract: LBA4509: efficacy results from the ToGA trial: a phase II study of trastuzumab added to standard chemotherapy in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC).
Keywords: immunohistochemistry; survival; chemotherapy, cancer -- adverse effects; chemotherapy, cancer; her-2-neu oncogene; stomach neoplasms -- drug therapy; trastuzumab -- administration and dosage; doxorubicin -- analogs and derivatives; fluorouracil -- administration and dosage
Journal Title: ASCO News & Forum
Volume: 4
Issue: 4
ISSN: 1931-7646
Publisher: American Society of Clinical Oncology  
Date Published: 2009-10-01
Start Page: 38
End Page: 39
Language: English
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:

http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=2010570439&site=ehost-live
Notes: --- - "Accession Number: 2010570439" - "Entry Date: 20100319" - "Publication Type: journal article; equations & formulas; tables/charts" - "Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Online/Print; Peer Reviewed; USA" - "Special Interest: Oncologic Care" - "Source: cin20"